JOHNSON & JOHNSON Financing Cash Flow 2007-2026 | JNJ
Beta
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is JOHNSON & JOHNSON's current financing cash flow?
JOHNSON & JOHNSON (JNJ) annual financing cash flow for 2025 was $-5.54B, a 76.85% decline from 2024. JOHNSON & JOHNSON financing cash flow for the quarter ending March 29, 2026 was $530.0M.
What was JOHNSON & JOHNSON's financing cash flow in 2024?
JOHNSON & JOHNSON annual financing cash flow for 2024 was $-3.13B, a 80.21% increase from 2023.
What was JOHNSON & JOHNSON's financing cash flow in 2023?
JOHNSON & JOHNSON annual financing cash flow for 2023 was $-15.82B, a 12.66% decline from 2022.
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2019
$-18.02B
→
FY2025
$-5.54B
07081011121314161718192122232425
5 years selected
Financing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-5.54B | -76.9% | 10-K |
| FY2024 | $-3.13B | +80.2% | 10-K |
| FY2023 | $-15.82B | -12.7% | 10-K |
| FY2022 | $-14.05B | -129.5% | 10-K |
| FY2021 | $-6.12B | +66.0% | 10-K |
| FY2019 | $-18.02B | +2.7% | 10-K |
| FY2018 | $-18.51B | -141.2% | 10-K |
| FY2017 | $-7.67B | +31.1% | 10-K |
| FY2016 | $-11.14B | +10.9% | 10-K |
| FY2014 | $-12.50B | -105.2% | 10-K |
| FY2013 | $-6.09B | +70.4% | 10-K |
| FY2012 | $-20.56B | -312.9% | 10-K |
| FY2011 | $-4.98B | -21.7% | 10-K |
| FY2010 | $-4.09B | +45.2% | 10-K |
| FY2008 | $-7.46B | -31.0% | 10-K |
| FY2007 | $-5.70B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →